He, Xirui
Zunyi Medical University,
China
2025 Rank: 101886
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 358 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 101886 | 108388 |
| Total Cites | 771 | 796 |
| H-index | 16 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 350 | 357 |
| Number of Single+First+Last Authored Papers | 20 | 20 |
| Total Cites to Single+First+Last Authored Papers | 366 | 375 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 759 | 769 |
| Ratio of Total Citations to Distinct Citing Papers | 1.02 | 1.04 |
| Self-Citation Percentage |
3.14%
|
|
He, Xirui
Zunyi Medical University,
China
2024 Rank: 102282
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 354 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102282 | 114886 |
| Total Cites | 672 | 694 |
| H-index | 16 | 16 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 339 | 343 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 350 | 354 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 658 | 670 |
| Ratio of Total Citations to Distinct Citing Papers | 1.02 | 1.04 |
| Self-Citation Percentage |
3.17%
|
|
He, Xirui
Zunyi Medical University,
China
2023 Rank: 112475
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 419 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 112475 | 126021 |
| Total Cites | 653 | 677 |
| H-index | 15 | 15 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 311 | 315 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 317 | 321 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 640 | 652 |
| Ratio of Total Citations to Distinct Citing Papers | 1.02 | 1.04 |
| Self-Citation Percentage |
3.55%
|
|
He, Xirui
Zunyi Medical University,
China
2022 Rank: 161824
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Complementary & Alternative Medicine
Rank in SubField 1: 620 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 161824 | 185495 |
| Total Cites | 431 | 445 |
| H-index | 13 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 240 | 242 |
| Number of Single+First+Last Authored Papers | 14 | 14 |
| Total Cites to Single+First+Last Authored Papers | 240 | 242 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 420 | 427 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.04 |
| Self-Citation Percentage |
3.15%
|
|
He, Xirui
Zunyi Medical University,
China
2021 Rank: 222220
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Complementary & Alternative Medicine
Rank in SubField 1: 934 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 222220 | 234117 |
| Total Cites | 547 | 571 |
| H-index | 12 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 324 | 331 |
| Number of Single+First+Last Authored Papers | 13 | 13 |
| Total Cites to Single+First+Last Authored Papers | 324 | 331 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 530 | 548 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.04 |
| Self-Citation Percentage |
4.20%
|
|
He, Xirui
Zunyi Medical University,
China
2020 Rank: 267704
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 1275 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 267704 | 289957 |
| Total Cites | 319 | 340 |
| H-index | 10 | 10 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 201 | 208 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 201 | 208 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 315 | 328 |
| Ratio of Total Citations to Distinct Citing Papers | 1.01 | 1.04 |
| Self-Citation Percentage |
6.18%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.